Webinar Presented By: BBK Worldwide
With more than 7,000 rare diseases and fewer than 500 therapies, we must work together to improve clinical trial processes and, ultimately, the pipeline of new treatments.
In advance of Rare Disease Day® 2016, industry experts from the National Organization for Rare Disorders (NORD), Xenon Pharmaceuticals andBBK Worldwide will discuss the direction of rare disease clinical research. With advancements in genomics and genetic analysis, and the rise of patient-centric thinking, streamlining processes and improved multi-stakeholder engagement are more important than ever. Please join this complimentary webinar for a thoughtful discussion on the challenges and opportunities in rare disease research.
|Pamela Gavin — Chief Operating Officer, NORD|
|Y. Paul Goldberg — Vice President of Clinical Development, Xenon Pharmaceuticals|
|Bonnie A. Brescia — Founding Principal, BBK Worldwide|